PYGL and type 2 diabetes mellitus: In the livers of the two kinds of T2D mice, GCN2iB treatment resulted in a significant decrease in PYGL protein expression and increases in GLUT2, GCK, and PDHB protein expression and AKT phosphorylation (Figure 3K).